Back
Endava Plc Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Sell
29
DAVA
Endava Plc
Last Price:
$6.69
Seasonality Move:
-3.62%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$68.84
Seasonality Move:
40.49%
Sell
29
Endava Plc (DAVA)
is a Sell
Is Endava Plc a Buy, Sell or Hold?
-
The current Endava Plc [DAVA] share price is $6.67. The Score for DAVA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
DAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.83. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAVA Stock Price Chart
What is Endava Plc's stock price today?
-
The Endava Plc share price today is $6.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAVA is experiencing slight buying pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $68.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
DAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.47 | Sell |
| Relative Strength Index (14 RSI): | 43.36 | Sell |
| Chaikin Money Flow: | 325780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.91 - 8.03) | Sell |
| Bollinger Bands (100): | (7.35 - 12.65) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.39 | Buy |
| Relative Strength Index (14 RSI): | 76.07 | Buy |
| Chaikin Money Flow: | 2789125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.57 - 58.79) | Buy |
| Bollinger Bands (100): | (20.11 - 45.67) | Buy |
DAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.43 | Buy |
| 20-day SMA: | 6.47 | Buy |
| 50-day SMA: | 7.98 | Sell |
| 200-day SMA: | 13.94 | Sell |
| 8-day EMA: | 6.51 | Buy |
| 20-day EMA: | 6.8 | Sell |
| 50-day EMA: | 7.6 | Sell |
| 200-day EMA: | 5.56 | Buy |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.94 | Buy |
| 20-day SMA: | 50.39 | Buy |
| 50-day SMA: | 42.93 | Buy |
| 200-day SMA: | 24.04 | Buy |
| 8-day EMA: | 62.02 | Buy |
| 20-day EMA: | 53.73 | Buy |
| 50-day EMA: | 44.48 | Buy |
| 200-day EMA: | 29.61 | Buy |
Endava Plc Earnings Growth & DAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.47 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
Endava Plc Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||